Institut für Experimentelle und Klinische Pharmakologie und Toxikologie

Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center (2023) Cuba L, Schlichtig K, Dürr P, Inwald EC, Fromm M, Dörje F Journal article Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs (2023) Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, et al. Journal article, Original article C1q/TNF-Related Proteins 1, 6 and 8 Are Involved in Corneal Epithelial Wound Closure by Targeting Relaxin Receptor RXFP1 In Vitro (2023) Nicolaus H, Klonisch T, Paulsen F, Garreis F Journal article Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines (2023) Haberkorn B, Löwen D, Meier L, Fromm M, König J Journal article Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells (2023) Zimmermann T, Stäbler S, Taudte RV, Ünüvar S, Groesch S, Arndt S, Karrer S, et al. Journal article Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021 (2023) Then M, Tuemena T, Sledziewska A, Gassmann KG, Maas R, Fromm M Journal article, Original article The impact of HCN4 channels on CNS brain networks as a new target in pain development (2023) Häfele M, Kreitz S, Ludwig A, Heß A, Wank I Journal article L-Arginine metabolism inhibits arthritis and inflammatory bone loss (2023) Cao S, Li Y, Song R, Meng X, Fuchs M, Liang C, Kachler K, et al. Journal article Junctional Ectopic Tachycardia Caused by Junctophilin-2 Expression Silencing Is Selectively Sensitive to Ryanodine Receptor Blockade (2023) Yang Q, Tadros HJ, Sun B, Bidzimou MT, Ezekian JE, Li F, Ludwig A, et al. Journal article A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: Focus on oral antitumor agents (2023) Kehl N, Geßner A, Maas R, Fromm M, Taudte V Journal article